Allspring Global Investments Holdings LLC Has $21.98 Million Stake in Integer Holdings Co. (NYSE:ITGR)

Allspring Global Investments Holdings LLC cut its position in Integer Holdings Co. (NYSE:ITGR) by 14.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 166,303 shares of the medical equipment provider’s stock after selling 28,375 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.50% of Integer worth $21,980,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Blue Trust Inc. raised its position in Integer by 4.4% during the fourth quarter. Blue Trust Inc. now owns 1,689 shares of the medical equipment provider’s stock valued at $220,000 after purchasing an additional 71 shares in the last quarter. HighTower Advisors LLC raised its holdings in shares of Integer by 0.8% during the 3rd quarter. HighTower Advisors LLC now owns 12,041 shares of the medical equipment provider’s stock worth $1,579,000 after buying an additional 90 shares in the last quarter. Mather Group LLC. boosted its stake in Integer by 304.3% in the fourth quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 143 shares in the last quarter. Exchange Traded Concepts LLC grew its position in Integer by 2.6% in the fourth quarter. Exchange Traded Concepts LLC now owns 5,800 shares of the medical equipment provider’s stock valued at $769,000 after acquiring an additional 145 shares during the last quarter. Finally, Versant Capital Management Inc raised its stake in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock worth $49,000 after acquiring an additional 183 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. KeyCorp lifted their price target on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Benchmark upped their price target on shares of Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Truist Financial raised their price objective on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Piper Sandler reiterated an “overweight” rating and issued a $140.00 target price (up from $125.00) on shares of Integer in a research report on Friday, October 25th. Finally, Citigroup lifted their price target on Integer from $130.00 to $145.00 and gave the company a “neutral” rating in a research note on Wednesday, December 11th. One research analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $146.56.

Integer Price Performance

Shares of ITGR opened at $140.94 on Friday. The business has a 50-day moving average of $137.84 and a 200-day moving average of $131.73. Integer Holdings Co. has a 1 year low of $94.56 and a 1 year high of $146.36. The company has a market capitalization of $4.73 billion, a price-to-earnings ratio of 43.50, a price-to-earnings-growth ratio of 1.79 and a beta of 1.13. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.